DS

Damodar Sadula

Active Director Director DIN 09689511
DIN 09689511 First appointment Jul 2022 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value •••• Premium profile

About Damodar Sadula

Data last updated:

Damodar Sadula is a Director at Primero Life Sciences Private Limited (since 2022). The company operates in Trading. Primero Life Sciences Private Limited reported revenue of ₹1.06 Cr (FY 2025).

DIN 09689511
Primary Designation Director
Industry Trading
First Appointment 28 Jul 2022
Oldest Company Age 4 yrs
Largest company Primero Life Sciences Private Limited · ₹1.06 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Jul 20222022₹1.06 Cr (FY 2025)Active

Board colleagues of Damodar Sadula

Directorship timeline

Open interactive timeline →
Primero Life Sciences Private Limited
Premium access

Shareholding and investment profile for Damodar Sadula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Damodar Sadula

Damodar Sadula currently holds 1 directorship: Primero Life Sciences Private Limited (Director, since 28 Jul 2022, revenue ₹1.06 Cr (FY 2025)).

Damodar Sadula was first appointed on 28 Jul 2022 as Director at Primero Life Sciences Private Limited.

The current boards of Damodar Sadula's companies include Dhanalaxmi Sadula (Primero Life Sciences Private Limited), Sumankumar Sadula (Primero Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available